Imatinib Mesylate: In the Treatment of Gastrointestinal Stromal Tumours

By Croom K.F.   Perry C.M.  

Drugs, Vol. 63, Iss. 5, 2003-01 ,pp. : 513-522

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Imatinib Mesylate in the Treatment of Advanced Gastrointestinal Stromal Tumours

By Huse Daniel M.  

Clinical Drug Investigation, Vol. 27, Iss. 2, 2007-01 ,pp. : 85-93

Adis International

Access to resources Recommend Favorite

Benefit-Risk Assessment of Sunitinib in Gastrointestinal Stromal Tumours and Renal Cancer

By Theou-Anton Nathalie   Faivre Sandrine   Dreyer Chantal   Raymond Eric  

Drug Safety, Vol. 32, Iss. 9, 2009-09 ,pp. : 717-734

Adis International

Access to resources Recommend Favorite

Phase I/II study of sunitinib malate in Japanese patients with gastrointestinal stromal tumor after failure of prior treatment with imatinib mesylate

By Shirao Kuniaki   Nishida Toshirou   Doi Toshihiko   Komatsu Yoshito   Muro Kei   Li Yinhua   Ueda Eiji   Ohtsu Atsushi  

Investigational New Drugs, Vol. 28, Iss. 6, 2010-12 ,pp. : 866-875

Springer Publishing Company

Access to resources Recommend Favorite

Imatinib mesilate for the treatment of gastrointestinal stromal tumour

By Cassier Philippe A   Dufresne Armelle   Arifi Samia   Sayadi Hiba El   Labidi Intidar   Ray-Coquard Isabelle   Tabone Séverine   Méeus Pierre   Ranchère Dominique   Sunyach Marie-Pierre   Decouvelaere Anne-Valérie   Alberti Laurent   Blay Jean-Yves  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 7, 2008-05 ,pp. : 1211-1222

Informa Healthcare

Access to resources Recommend Favorite